New Delhi: The government has asked stent manufacturers to maintain uninterrupted supply of coronary stents by invoking emergency clause in public interest. The move comes in the wake of various multinationals, including Abbott and Medtronic, seeking permission to withdraw some of their products from India following price control. \r\nThe Department of Pharmaceuticals (DoP) has invoked an emergency clause of the Drug Price Control Order, 2013, in public interest to ensure the companies complied with its direction. The government took action after receiving reports of shortage of stents in the market and hospitals. |
